|
General Information
|
|
|
Product
|
PDE2A3 Peptide
|
|
Description
|
Antigenic Blocking Peptide Phosphodiesterase 2A3
|
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
|
Peptide Description
|
Synthetic peptide corresponding to region within amino acids 1-50 on N-terminus of human PDE2A3 protein.
|
|
Accession #
|
NCBI: NP_002590.1
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Determinant
|
N-epitope
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
O00408
|
|
Overview
|
Cyclic nucleotide phosphodiesterase with a dual-specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes.
|
|
Molecular Function
|
Calcium channel activity, cAMP binding, cGMP binding, cGMP-stimulated cyclic-nucleotide phosphodiesterase activity; drug binding; metal ion binding; protein homodimerization activity; TPR domain binding
|
|
Subcellular Location
|
Cell membrane; Lipid-anchor
|
|
Expression
|
Expressed in brain and to a lesser extent in heart, placenta, lung, skeletal muscle, kidney and pancreas.
|
|
Structure
|
Belongs to the cyclic nucleotide phosphodiesterase family. PDE2 subfamily.
Contains 2 GAF domains.
|
|
Alternative Nomenclature
|
Phosphodiesterase 2A 3
|
| |
|
PDE2A3 Positive Control
PDE2A3 Antibody
PDE2A3 Antibody BIOTIN
PDE2A3 Antibody FITC
